Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBFC:TH

624.1110 EUR 0.00000.00%

As of 07:37:34 ET on 04/15/2015.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBFC)

Open: - High - Low: - Primary Exchange: Tradegate
Volume: 50 52-Week Range: 287.1900 - 646.6470 Beta vs NSESWRLD: 0.8919

ETF Chart for UBFC

No chart data available.
  • UBFC:TH 624.1110
  • 1D
  • 1M
  • 1Y
624.1110
Interactive UBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFC

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: 1996-10-15 Telephone: 352-44-10-10-1 Tel
Managers: NATHALIE LOTSCHER PETRUS / SARAH COTTER
Web Site: www.ubs.com

Fundamentals for UBFC

NAV -
Assets (M) (on 2015-04-16) 1,965.3290
Shares out (M) 2.85
Market Cap (M) 1,775.69
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFC

No dividends reported

Performance for UBFC

1-Month -0.37% 1-Year +122.10%
3-Month +24.61% 3-Year -
Year To Date +34.84% 5-Year -
Expense Ratio 2.08

Top Fund Holdings for UBFC

Filing Date: 02/28/2015
Name Position Value % of Total
Biogen Inc 405,200 165,965,868 9.707%
Gilead Sciences Inc 1,538,500 159,280,905 9.316%
Amgen Inc 813,714 128,338,972 7.506%
Celgene Corp 996,620 121,119,229 7.084%
BioMarin Pharmaceutical Inc 899,100 96,266,637 5.631%
Vertex Pharmaceuticals Inc 696,100 83,135,223 4.863%
Alexion Pharmaceuticals Inc 449,800 81,130,426 4.745%
Medivation Inc 582,600 68,472,978 4.005%
Alkermes PLC 961,893 67,572,983 3.952%
Pharmacyclics Inc 278,066 60,042,791 3.512%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil